Mobilização por medicamentos para doenças raras
15 de maio de 2019
O Supremo Tribunal Federal (STF) deve retomar o julgamento de processos sobre a obrigatoriedade do poder público fornecer medicamentos de alto custo, mesmo aqueles não
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.